Research & Innovation - Participant Portal


Opening Date 11-12-2013 Deadline Date 17-09-2014 17:00:00 (Brussels local time)
Publication date 11-12-2013 Total Call Budget €85,870,000
Programme Horizon 2020
Status Closed Main Pillar EURATOM
OJ reference OJ C361 of 11 December 2013

Topic: High density uranium fuel and targets for the production of medical radioisotopes NFRP-08-2015

Specific Challenge: A shortage of Molybdenum-99 has occurred mainly as a result of the low availability of research reactor facility and of the extensive replacement of highly enriched uranium fuel by low enriched one to address nuclear proliferation concerns. This has been at the origin of the European Observatory on the Supply of Medical Radioisotopes[1], created in order to organise the availability of this essential radiopharmaceutical product.

Research and innovation should be undertaken to support the replacement of highly enriched uranium fuel and targets by low enriched and high density ones. The issue for the fuel is the sufficient performance and safe operation of the reactor, notably for preserving the fuel elements from meltdown, e.g. in using an appropriate conditioning. The issue for the targets is to achieve a sufficient number of fission reactions that produce Molybdenum-99 and to get a high quality pharmaceutical product.

Scope: This research and innovation will focus on developing new kinds of high density uranium fuel and targets bearing in mind their thermal, mechanical and chemical behaviour and their suitability for use in different research reactors. This will involve inter alia the investigation of heat resistance, preserved microstructure, reduced oxidation and thermal fatigue of high density fuel and targets by appropriate coating. Fuel and target fabrication will be studied in view of testing their properties under thermal stress before and after irradiation. International cooperation could be beneficial in this area.

Impact: The cost effective supply of high density and low enriched uranium fuel and targets will allow the more efficient use of research reactors in Europe for the purpose of energy research and the production of medical radioisotopes like Molybdenum-99. This will contribute to the addressing of key challenges of Horizon 2020 in the sectors of energy and health. The principal impact of this action will be the prevention of future crises in the supply of Molybdenum-99.

Type of action: Research and innovation actions.

Additional information: The Commission considers that proposals requesting a contribution from the Euratom of between EUR 4 and 6 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.


Please read carefully all provisions below before the preparation of your application.

  1. List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
  2. Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme
  3. Evaluation

    3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme

    3.2 Guide to the submission and evaluation process
  4. Proposal page limits and layout: Please refer to Part B of the standard proposal template.
  5. Indicative timetable for evaluation and grant agreement:
    Information on the outcome of one-stage evaluation: maximum 5 months from the final date for submission.
    Signature of grant agreements: maximum 3 months from the date of informing successful applicants.
  6. Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:

    Research and Innovation Action:

    Specific provisions and funding rates
    Standard proposal template (administrative forms and structure of technical annex)
    Standard evaluation form
    Annotated Model Grant Agreement
  7. Additional provisions:

    Horizon 2020 budget flexibility

    Classified information

  8. Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.


Additional documents

You can download the same documents as one zip file from the call page

  • Flash Call Info en
  • Legal basis - Framework Programme H2020 en
  • Legal basis - Programme Euratom en
  • Legal basis - Rules for Participation en
  • Legal basis - Specific Programme H2020 en
  • Euratom - Work Programme en
  • WP H2020 - 19. General Annexes en

No submission system is open for this topic.